Quick Links: About Us   Contact Us   Donations   Language:
French (Fr)English (United Kingdom)
Twitter Twitter
logo
CHEP_Banner__
Home CHEP References

References

  1. Wolf-Maier, K., Cooper, R.S., Kramer, H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-17.
  2. Yusuf, S., Hawken, S., Ounpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937-952.
  3. Kannel, W.B. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA. 1996;275:1571-1576.
  4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
  5. Padwal, R.S., Hemmelgarn, B.R., McAlister, F.A., et at. The 2007 Canadian hypertension education program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal Cardiology. 2007;23:529-538.
  6. Khan, N.A., Hemmelgarn, B., Padwal, R.,et al. The 2007 Canadian hypertension education program recommendations for the management of hypertension: Part 2 – therapy. Canadian Journal Cardiology. 2007;23:537-550.
  7. Padwal, R.S., Hemmelgarn, B.R., Khan, N.A., et at. The 2008 Canadian hypertension education program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal Cardiology. 2008;24:455-463.
  8. Khan, N.A., Hemmelgarn, B., Herman, R.J., et al. The 2008 Canadian hypertension education program recommendations for the management of hypertension: Part 2 – therapy. Canadian Journal Cardiology. 2008;24:465-475.
  9. Khan, N.A., Hemmelgarn, B., Herman, R.J., et al. The 2009 Canadian hypertension education program recommendations for the management of hypertension: Part 2 – therapy. Canadian Journal Cardiology. 2009;25:287-298.
  10. Padwal, R.S., Hemmelgarn, B.R., Khan, N.A., et al. The 2009 Canadian hypertension education program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal Cardiology. 2009;25:279-286.
  11. Zarnke, K.B, Campbell, N.R., McAlister, F.A., Levine,M. A novel process for updating recommendations for managing hypertension: Rationale and methods. Canadian Journal Cardiology. 2000;16:1094-1102.
  12. McAlister, F.A. The canadian hypertension education program – a unique Canadian initiative. Canadian Journal Cardiology. 2006;22:559-564.
  13. Beckett, L., Godwin,M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovascular Disorders. 2005;5:18-18.
  14. Myers, M.G., et al. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit. 2009;14:108-111.
  15. Campbell, N.R., Conradson, H.E., Kang, J., Brant, R., Anderson, T. Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse. Blood Press Monit. 2005;10:257-262.
  16. Myers, M.G., McInnis, N.H., Fodor, G.J., Leenen, F.H. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. 2008;21:280-283.
  17. Myers, M.G. Automated blood pressure measurement in routine clinical practice. Blood Press Monit. 2006;11:59-62.
  18. Myers, M.G., Godwin, M. Automated measurement of blood pressure in routine clinical practice. J Clin Hypertens (Greenwich). 2007;9:267-270.
  19. Wright, J.M., et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit. 2001;6:161-165.
  20. White, W.B., Anwar,Y.A. Evaluation of the overall efficacy of the omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6:107-110.
  21. Stergiou, G.S., et al. Validation of the Microlife Watch BP office professional device for office blood pressure measurement according to the international protocol. Blood Press Monit. 2008;13:299-303.
  22. Myers, M.G., Valdivieso, M., Kiss, A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280-286.
  23. Campbell, N.R., et al. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters. J Hum Hypertens. 2007;21:588-590.
  24. Hemmelgarn, B.R., McAlister, F.A., Myers, M.G., et al. The 2005 canadian hypertension education program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal Cardiology. 2005;21:645-656.
  25. Waldron, C.A., van der Weijden, T., Ludt, S., et al. What are effective strategies to communicate cardiovascular risk information to patients?  A systematic review. Patient Educ Couns. 2010 May 13. [Epub ahead of print]
  26. Grover, S.A., Lowensteyn, I., Joseph, L., et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: The CHECK-UP study: A randomized controlled trial. Arch Intern Med. 2007;167:2296-2303.
  27. Benner, J.S., Erhardt, L., Flammer, M., et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients’ modifiable risk factor profile. Int J Clin Pract. 2008;62:1484-1498.
  28. Soureti, A., Hurling, R., Murray, P., van Mechelen, W., Cobain, M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier
    lifestyles. Eur J Cardiovasc Prev Rehabil. 2010;17:519-523.
  29. D’Agostino, R.B., Ramachandran, S., Pencina, V.M., et al. General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation. 2008;117:743-753.
  30. Vasbinder, G.B., Nelemans, P.J., Kessels, A.G., et al. Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group: Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-682. 
  31. Postma, C.T., Joosten, F.B., Rosenbusch, G., Thien, T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens. 1997;10:957-963. 
  32. Sadowski, E.A., Bennett, L.K., Chan, M.R., et al. Nephrogenic systemic fibrosis: Risk factors and incidence estimation. Radiology. 2007;243:148-157. 
  33. Chrysochou, C., Power, A., Shurrab, A.E., et al. Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol. 2010;5:484-489. 
  34. Cassis, T.B., Jackson, J.M., Sonnier, G.B., Callen, J.P. Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol. 2006;45:56-59. 
  35. Jimenez, S.A., Artlett, C.M., Sandorfi, N., et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum. 2004;50:2660-2666. 
  36. Leesar, M.A., Varma, J., Shapira, A., et al. Prediction of hypertension improvement after stenting of renal artery stenosis: Comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363-2371.